Free Trial

Sartorius Stedim Biotech (DIM) News Today

Sartorius Stedim Biotech logo
€174.75 +0.25 (+0.14%)
As of 08/28/2025

DIM Latest News

Sartorius Stedim Biotech S.A. - Barron's
RBC Capital Sticks to Its Buy Rating for Sartorius Stedim Biotech (0RG8)
Sartorius Stedim Biotech releases Universal Registration Document 2024
Sartorius Stedim Biotech Preliminary FY24 Profit Declines - Quick Facts
Bernstein Sticks to Their Hold Rating for Sartorius Stedim Biotech (0RG8)
Sartorius Stock: JPMorgan Boost Drives 4% Market Surge
RBC Capital Sticks to Its Hold Rating for Sartorius (0NIR)
Jefferies Keeps Their Hold Rating on Sartorius (0NIR)
Jefferies Sticks to Their Hold Rating for Sartorius (0NIR)
Kepler Capital Remains a Sell on Sartorius (0NIR)
RBC Capital Keeps Their Buy Rating on Sartorius Stedim Biotech (0RG8)
J.P. Morgan Reaffirms Their Buy Rating on Sartorius (0NIR)
SDMHF Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech S.A. (56S1.DE)
Kepler Capital Sticks to Its Sell Rating for Sartorius (0NIR)
RBC Capital downgrades Sartorius (0NIR) to a Hold
Sartorius Stedim Biotech S.A. (DIMP.XC)
ViroCell Biologics Completes Oversubscribed Financing
Sartorius Stedim Biotech S.A. (SRTOY)
SRTOY Sartorius Stedim Biotech S.A.
Sartorius (0NIR) Receives a Buy from J.P. Morgan
Sartorius Stedim Biotech S.A. (DIM.VI)
Get Sartorius Stedim Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for DIM and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DIM Media Mentions By Week

DIM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DIM
News Sentiment

0.45

1.03

Average
Medical
News Sentiment

DIM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DIM Articles
This Week

1

0

DIM Articles
Average Week

Get the Latest News and Ratings for DIM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Sartorius Stedim Biotech and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (EPA:DIM) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners